Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...
Dynavax to Participate in Upcoming Investor Conferences
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in t ...
Dynavax Technologies (NASDAQ:DVAX) Upgraded by StockNews.com to “Buy” Rating
Dynavax Technologies (NASDAQ:DVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. A number ...
JMP Securities Keeps Their Buy Rating on Dynavax (DVAX)
JMP Securities analyst Jason Butler reiterated a Buy rating on Dynavax (DVAX – Research Report) today and set a price target of $33.00. The ...
William Blair Issues Pessimistic Estimate for DVAX Earnings
Research analysts at William Blair reduced their Q1 2025 earnings per share estimates for Dynavax Technologies in a report ...
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 20, 2025 Dynavax Technologies Corporation reports earnings inline with expectations ...
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors
Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies , pressing for new ...
Dynavax under fire as investor targets vaccine maker’s board
Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...
Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript
Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...